Bionomics Receives FDA Clearance of IND for Evaluation of BNC210 in a Phase 2 Social Anxiety Disorder PREVAIL Study

U.S. FDA clearance of IND for BNC210 evaluation as an acute treatment for patients with Social Anxiety Disorder in a...

Related Keywords

Australia ,United States ,Canada ,Adelaide ,South Australia ,Suzanne Irwin ,Connor Bernstein ,Merck Co Inc ,Corporate Development ,Drug Administration ,Bionomics Limited ,Contract Research Organisation ,Bionomics Or Company ,Social Anxiety Disorder ,Post Traumatic Stress Disorder ,Generalised Anxiety Disorder ,Subjective Units ,Distress Scale ,Good Clinical Practice ,Liebowitz Social Anxiety Scale ,Good Manufacturing Practice ,Bionomic Executive Chairman ,